e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
CPAP therapy for OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nasopharyngeal symptoms do not increase during nasal CPAP treatment
P. E. Brander, J. T. Lehto, A. M. Lindroth, T. S. Lahtinen (Hyvinkää, Finland)
Source:
Annual Congress 2004 - CPAP therapy for OSA
Session:
CPAP therapy for OSA
Session type:
Thematic Poster Session
Number:
3505
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. E. Brander, J. T. Lehto, A. M. Lindroth, T. S. Lahtinen (Hyvinkää, Finland). Nasopharyngeal symptoms do not increase during nasal CPAP treatment. Eur Respir J 2004; 24: Suppl. 48, 3505
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Nasopharyngeal symptoms do not predict poor adherence to nCPAP treatment
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Initial acceptance and compliance to nasal CPAP in elderly patients
Source: Annual Congress 2009 - Sleep apnoea across the ages
Year: 2009
Effect of CPAP on nasal resistance
Source: Eur Respir J 2004; 24: Suppl. 48, 573s
Year: 2004
Nasal budesonide ameliorates symptoms and polysomnography findings in children with chronic nasal obstruction and mild sleep-disordered breathing
Source: Eur Respir J 2003; 22: Suppl. 45, 391s
Year: 2003
Effect of heated humidification and topical steroids on compliance, nasal symptoms and quality of life in patients with obstructive sleep apnoea syndrome using nasal continuous positive airway pressure
Source: Eur Respir J 2006; 28: Suppl. 50, 412s
Year: 2006
Initiation of nasal CPAP therapy without a preceding sleep study?
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
Tolerability on nasal mucociliary clearance after long-term nCPAP treatment in severe OSAS patients
Source: Eur Respir J 2001; 18: Suppl. 33, 418s
Year: 2001
Nasal vs. oronasal mask: a real-life analysis in adults undergoing auto-adjusting CPAP titration.
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020
Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Alternatives for OSAHS treatment: selection of patients for upper airway surgery and oral appliances
Source: Eur Respir Rev 2007; 16: 132-145
Year: 2007
Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
CPAP increases bronchial reactivity in OSAS patients
Source: Eur Respir Rev 2008; 17: 101-102
Year: 2008
CPAP increases bronchial reactivity in OSAS patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Nasal CPAP in the therapy of OSAS – does a closer patient guidance and support increase compliance?
Source: Eur Respir J 2005; 26: Suppl. 49, 707s
Year: 2005
Compliance of positive airway pressure therapy in patients with sleep related breathing disorder
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Impact of biologic therapy in severe asthma with nasal polyps
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Optimal positive airway pressure predicts oral appliance response to sleep apnoea
Source: Eur Respir J 2010; 35: 1098-1105
Year: 2010
Successful treatment of severe laryngomalatia with nasal CPAP in an infant: an experience in Serbia-Montenegro
Source: Eur Respir J 2006; 28: Suppl. 50, 184s
Year: 2006
Measurement of snoring and stertor using the Sonomat to assess effectiveness of upper airway surgery in children
Source: Sleep and Breathing Conference 2021
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept